Position in BIOA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$840,643
+$436,694 QoQ
Shares Held
34,298
+48.5% QoQ
Ownership
0.075%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 151 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $1,001,919,079 across 44 Drug Manufacturers - Specialty & Generic names. BIOA ranks #31 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
5,851,737 | $420,505,812 | |
| 2 | VTRS |
Viatris Inc
|
7,891,271 | $125,313,379 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
195,269 | $105,802,598 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,037,225 | $102,901,179 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
334,650 | $56,401,907 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
248,743 | $27,595,547 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
323,443 | $26,774,610 | |
| 8 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
387,606 | $24,787,402 |
All Filings in BIOA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $840,643 | 34,298 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $403,949 | 23,096 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $208,981 | 15,796 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $148,911 | 25,325 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $104,592 | 25,325 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $27,275 | 7,254 | Shares | Defined | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||